BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1331999)

  • 1. Mu-delta opioid interactions. II: Beta-FNA inhibits DPDPE-induced increases in morphine EEG and EEG spectral power.
    Stamidis H; Young GA
    Peptides; 1992; 13(4):755-60. PubMed ID: 1331999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu-delta opioid interactions. III: Differential antagonism of DPDPE-induced increases in morphine EEG and EEG power spectra by DALCE and naltrindole.
    Stamidis H; Young GA
    Peptides; 1993; 14(3):511-7. PubMed ID: 8392719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu-delta opioid interactions. I: The delta peptide, DPDPE, increases morphine-induced EEG and EEG spectral power.
    Stamidis H; Young GA
    Peptides; 1992; 13(4):749-53. PubMed ID: 1331998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine.
    Calcagnetti DJ; Holtzman SG
    Pharmacol Biochem Behav; 1991 Jan; 38(1):185-90. PubMed ID: 2017444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the delta-opioid agonist, [D-Pen2,D-Pen5]-enkephalin, on fetal lamb EEG.
    Szeto HH; Cheng PY; Wu DL; Soong Y
    Pharmacol Biochem Behav; 1994 Dec; 49(4):795-800. PubMed ID: 7886089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists.
    Heyman JS; Jiang Q; Rothman RB; Mosberg HI; Porreca F
    Eur J Pharmacol; 1989 Oct; 169(1):43-52. PubMed ID: 2557223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrindole retards tolerance development to morphine-induced effects on EEG and EEG power spectra.
    Stamidis H; Young GA
    Eur J Pharmacol; 1992 Mar; 213(1):9-16. PubMed ID: 1499659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception.
    Liu-Chen LY; Li SX; Wheeler-Aceto H; Cowan A
    Eur J Pharmacol; 1991 Oct; 203(2):195-202. PubMed ID: 1666046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [D-Pen2, D-Pen5]enkephalin, the standard delta opioid agonist, induces morphine-like behaviors in mice.
    Murray CW; Cowan A
    Psychopharmacology (Berl); 1990; 102(3):425-6. PubMed ID: 2251341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta receptor involvement in morphine suppression of noxiously evoked activity of spinal WDR neurons in cats.
    Omote K; Kitahata LM; Nakatani K; Collins JG
    Brain Res; 1991 Jul; 554(1-2):299-303. PubMed ID: 1657291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used.
    Adams JU; Tallarida RJ; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1261-7. PubMed ID: 8396630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mu and delta opioid agonists and antagonists on affective vocal and reflexive pain responses during social stress in rats.
    Vivian JA; Miczek KA
    Psychopharmacology (Berl); 1998 Oct; 139(4):364-75. PubMed ID: 9809857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
    Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
    Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of delta-opioid receptors prevents morphine-induced place preference in mice.
    Suzuki T; Yoshiike M; Mizoguchi H; Kamei J; Misawa M; Nagase H
    Jpn J Pharmacol; 1994 Sep; 66(1):131-7. PubMed ID: 7861658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
    Heyman JS; Mulvaney SA; Mosberg HI; Porreca F
    Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of mu 1- and delta-opioid receptors in modulation of fetal EEG and respiratory activity.
    Cheng PY; Wu D; Soong Y; McCabe S; Decena JA; Szeto HH
    Am J Physiol; 1993 Aug; 265(2 Pt 2):R433-8. PubMed ID: 8396355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
    Sánchez-Blázquez P; Garzón J
    Eur J Pharmacol; 1989 Jan; 159(1):9-23. PubMed ID: 2565240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a highly selective nonpeptide delta opioid receptor agonist, TAN-67, on morphine-induced antinociception in mice.
    Suzuki T; Tsuji M; Mori T; Misawa M; Endoh T; Nagase H
    Life Sci; 1995; 57(2):155-68. PubMed ID: 7603296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
    Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.